BACKGROUND Vascular access site management is crucial to safe, efficient, and comfortable diagnostic or interventional percutaneous procedures. The Angioseal™ vascular closure device has been shown to be safe and effective in reducing the time to hemostasis following angiographic or interventional procedures. Relatively few studies have been conducted in the UK to assess the safety and efficacy...

Introduction: The SYS-CAPLIOX trial uses an implantable vascular access device (AVAS®) for repeated liver isolation intra-arterial oxaliplatin (LIOX) patients with inoperable colorectal cancer metastases (CRCLM). Similar to selective internal radiation therapy (SIRT), transarterial chemoembolization (TACE) and hepatic arterial infusion (HAI), the LIOX technique negates puncture has reduced surg...